Author Archives: admin

Extraordinary Information Disclosure Date 14 August 2026
14 August, 2026

[...]

Ha Tay Pharmaceutical Strengthens Strategic Partnership, Learns Best Practices from Japan’s ASKA Pharmaceutical

With the goal of continuously enhancing management capacity and realizing its vision for international integration, [...]

01
Aug
Consolidated Financial Statement Quarter 2 – 2026
29 July, 2026

[...]

Financial Statement Quarter 2 – 2026
29 July, 2026

[...]

Resolution of the Company’s Board of Directors Meeting dated July 24th, 2026
24 July, 2026

[...]

Resolution on the implementation of the 2026 plan on share issuance to increase share capital from owner’s equity
24 July, 2026

[...]

Report on Corporate Governance ( first half of 2026)
16 July, 2026

[...]

Ha Tay Pharmaceutical Honored with “Disclosure Best Practice 2026”

Ha Tay Pharmaceutical Joint Stock Company (stock code: DHT) has recently been honored with the [...]

08
Jul
Mr. MASAYUKI TANAKA

[...]

01
Jul
Mr. Dinh Nam Ha

[...]

01
Jul